arginine has been researched along with tamoxifen in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (16.67) | 18.7374 |
| 1990's | 2 (8.33) | 18.2507 |
| 2000's | 5 (20.83) | 29.6817 |
| 2010's | 11 (45.83) | 24.3611 |
| 2020's | 2 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Groom, GV; Paterson, AG; Turkes, A; Webster, DJ | 1 |
| Bell, DR; Koritnik, DR; Koshy, A; Rensberger, HJ | 1 |
| Alalami, O; Martin, JH | 1 |
| Bell, DW; Garber, JE; Gray, H; Haber, DA; Iglehart, DJ; Kaelin, CM; Lunetta, KL; Marks, JR; Nasser, SM; Polyak, K; Rhei, E; Seth, P | 1 |
| Cartwright, JE; Holden, DP; Nussey, SS; Whitley, GS | 1 |
| Nishio, I; Tsuda, K | 1 |
| Flamant, F; Quignodon, L; Samarut, J; Vincent, S; Winter, H | 1 |
| Büssemaker, E; Hagedorn, C; Hausberg, M; Hillebrand, U; Kliche, K; Lang, D; Oberleithner, H; Pavenstädt, H; Reuter, S; Stock, CM; Telgmann, RG | 1 |
| Grisotti, G; Roos, RP; Wang, L | 1 |
| Birzniece, V; Ho, KK; Sata, A; Sutanto, S | 2 |
| Andreatini, R; Chioca, LR; Correia, D; Pereira, M; Pizzolatti, MG; Santos, AR; Siba, IP; Vital, MA | 1 |
| Birzniece, V; Ho, KK; Sutanto, S | 1 |
| Cheatham, TE; Shahrokh, K; Yost, GS | 1 |
| Bernhardt, G; Buschauer, A; Keller, M; Lopuch, M; Memminger, M; Pop, N; von Angerer, E | 1 |
| Al-Dhabi, NA; Arasu, MV; Arockiaraj, J; Arshad, A; Charles, S; Madhavan, T; Mala, K; Munusamy-Ramanujam, G; Saraswathi, NT; Singh, P | 1 |
| Carlström, M; Cortese-Krott, MM; Grandoch, M; Guimaraes Braga, DD; Heuser, SK; Kelm, M; Leo, F; Li, J; LoBue, A; Lundberg, JO; Montero, L; Olsson, A; Pernow, J; Schmitt, JP; Schmitz, OJ; Schneckmann, R; Srivrastava, T; Suvorava, T; Weitzberg, E; Zhuge, Z | 1 |
| Schwarz, MA; Snyder, RD | 1 |
| Pawlicki, M; Zuchowska-Vogelgesang, B | 1 |
| Asselain, B; Bretaudeau, B; Garcia-Giralt, E; Jouve, M; Magdelenat, H; Palangie, T; Pouillart, P | 1 |
2 review(s) available for arginine and tamoxifen
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[New antineoplastic agents, their value and use].
Topics: Aminacrine; Antineoplastic Agents; Aspartic Acid; Cisplatin; Etoposide; Humans; Ifosfamide; Interferons; Medroxyprogesterone; Medroxyprogesterone Acetate; Methyltestosterone; Neoplasms; Phosphonoacetic Acid; Razoxane; Tamoxifen; Teniposide; Vinca Alkaloids | 1982 |
4 trial(s) available for arginine and tamoxifen
| Article | Year |
|---|---|
Paracrine regulation of growth hormone secretion by estrogen in women.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Arginine; Cross-Over Studies; Dose-Response Relationship, Drug; Estradiol; Female; Human Growth Hormone; Humans; Insulin-Like Growth Factor I; Middle Aged; Paracrine Communication; Postmenopause; Radioimmunoassay; Sex Hormone-Binding Globulin; Tamoxifen | 2010 |
Neuroendocrine regulation of growth hormone and androgen axes by selective estrogen receptor modulators in healthy men.
Topics: Aged; Androgens; Arginine; Cross-Over Studies; Follicle Stimulating Hormone; Growth Hormone; Humans; Insulin-Like Growth Factor I; Luteinizing Hormone; Male; Middle Aged; Raloxifene Hydrochloride; Reference Values; Selective Estrogen Receptor Modulators; Sex Hormone-Binding Globulin; Tamoxifen; Testosterone | 2010 |
Gender difference in the neuroendocrine regulation of growth hormone axis by selective estrogen receptor modulators.
Topics: Aged; Aged, 80 and over; Arginine; Cross-Over Studies; Dose-Response Relationship, Drug; Female; Human Growth Hormone; Humans; Insulin-Like Growth Factor I; Liver; Luteinizing Hormone; Male; Middle Aged; Neurosecretion; Pituitary Gland, Anterior; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Sex Characteristics; Sex Hormone-Binding Globulin; Tamoxifen; Testosterone | 2012 |
[Metastatic breast cancer: controlled trial of chemotherapy with and without hormones].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Mitomycin; Mitomycins; Norethindrone; Tamoxifen; Teniposide; Vincristine | 1984 |
18 other study(ies) available for arginine and tamoxifen
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
The effect of tamoxifen on plasma growth hormone and prolactin in postmenopausal women with advanced breast cancer.
Topics: Aged; Arginine; Breast Neoplasms; Female; Growth Hormone; Humans; Menopause; Middle Aged; Prolactin; Tamoxifen | 1983 |
Estrogen pretreatment directly potentiates endothelium-dependent vasorelaxation of porcine coronary arteries.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Animals; Arginine; Calcimycin; Coronary Vessels; Dose-Response Relationship, Drug; Endothelium, Vascular; Estradiol; Female; In Vitro Techniques; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Nitroarginine; Nitroglycerin; Orchiectomy; Prostaglandin Endoperoxides, Synthetic; Reference Values; Sex Characteristics; Swine; Tamoxifen; Thromboxane A2; Vasoconstrictor Agents; Vasodilation | 1995 |
ZR-75-1 human breast cancer cells: expression of inducible nitric oxide synthase and effect of tamoxifen and phorbol ester on nitric oxide production.
Topics: Arginine; Breast Neoplasms; Female; Humans; Immunoenzyme Techniques; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Tamoxifen; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 1998 |
Phenol sulfotransferases: hormonal regulation, polymorphism, and age of onset of breast cancer.
Topics: Adult; Age of Onset; Alleles; Arginine; Arylsulfotransferase; Blotting, Northern; Breast Neoplasms; Case-Control Studies; Estrogens; Exons; Female; Genotype; Histidine; Humans; Immunoblotting; Middle Aged; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Reverse Transcriptase Polymerase Chain Reaction; Risk Factors; RNA, Messenger; Tamoxifen; Tumor Cells, Cultured | 2000 |
Estrogen stimulates dimethylarginine dimethylaminohydrolase activity and the metabolism of asymmetric dimethylarginine.
Topics: Amidohydrolases; Arginine; Cardiotonic Agents; Cell Line; Drug Implants; Endothelium, Vascular; Enzyme Activation; Estradiol; Female; Humans; Middle Aged; Postmenopause; Receptors, Estrogen; Tamoxifen | 2003 |
A selective estrogen receptor modulator, tamoxifen, and membrane fluidity of erythrocytes in normotensive and hypertensive postmenopausal women: an electron paramagnetic resonance investigation.
Topics: Aged; Analysis of Variance; Arginine; Cyclic GMP; Dose-Response Relationship, Drug; Drug Synergism; Electron Spin Resonance Spectroscopy; Enzyme Inhibitors; Erythrocyte Membrane; Erythrocytes; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Humans; Hypertension; Membrane Fluidity; NG-Nitroarginine Methyl Ester; Nitric Oxide Donors; Nitric Oxide Synthase; Postmenopause; S-Nitroso-N-Acetylpenicillamine; Selective Estrogen Receptor Modulators; Tamoxifen | 2005 |
A point mutation in the activation function 2 domain of thyroid hormone receptor alpha1 expressed after CRE-mediated recombination partially recapitulates hypothyroidism.
Topics: Alleles; Amino Acid Substitution; Animals; Arginine; Bone and Bones; Genes, Dominant; Hypothyroidism; Integrases; Leucine; Mice; Mice, Transgenic; Point Mutation; Recombination, Genetic; Tamoxifen; Thyroid Hormone Receptors alpha; Thyroid Hormone Receptors beta | 2007 |
Nebivolol decreases endothelial cell stiffness via the estrogen receptor beta: a nano-imaging study.
Topics: Adenocarcinoma; Adrenergic beta-Antagonists; Antihypertensive Agents; Arginine; Benzopyrans; Breast Neoplasms; Cell Line; Cell Line, Tumor; Cell Size; Dose-Response Relationship, Drug; Drug Combinations; Elasticity; Endothelial Cells; Estradiol; Estrogen Antagonists; Estrogen Receptor beta; Estrogen Receptor Modulators; Estrogens; Ethanolamines; Female; Fulvestrant; Genes, Reporter; Humans; Metoprolol; Nanotechnology; Nebivolol; Nitric Oxide; Nitrites; Tamoxifen; Time Factors; Transfection | 2009 |
Mutant SOD1 knockdown in all cell types ameliorates disease in G85R SOD1 mice with a limited additional effect over knockdown restricted to motor neurons.
Topics: Amyotrophic Lateral Sclerosis; Animals; Arginine; Disease Models, Animal; Estrogen Antagonists; Glycine; Humans; Mice; Mice, Transgenic; Motor Neurons; Mutation; RNA, Messenger; Spinal Cord; Superoxide Dismutase; Superoxide Dismutase-1; Tamoxifen; Time Factors | 2010 |
Myricitrin, a nitric oxide and protein kinase C inhibitor, exerts antipsychotic-like effects in animal models.
Topics: Animals; Antipsychotic Agents; Apomorphine; Arginine; Catalepsy; Disease Models, Animal; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Flavonoids; Indazoles; Male; Mice; Motor Activity; Nitric Oxide; Phytotherapy; Plant Leaves; Plant Preparations; Protein Kinase C; Psychotic Disorders; Rats; Rats, Wistar; Stereotyped Behavior; Syzygium; Tamoxifen | 2011 |
Conformational dynamics of CYP3A4 demonstrate the important role of Arg212 coupled with the opening of ingress, egress and solvent channels to dehydrogenation of 4-hydroxy-tamoxifen.
Topics: Arginine; Cytochrome P-450 CYP3A; Humans; Hydrogenation; Ion Channel Gating; Models, Biological; Models, Molecular; Molecular Docking Simulation; Molecular Dynamics Simulation; Mutagenesis, Site-Directed; Protein Binding; Protein Conformation; Protein Interaction Domains and Motifs; Solvents; Tamoxifen | 2012 |
The neuropeptide y y(1) receptor: a diagnostic marker? Expression in mcf-7 breast cancer cells is down-regulated by antiestrogens in vitro and in xenografts.
Topics: Animals; Arginine; Breast Neoplasms; Calcium; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Estradiol; Estrogen Receptor Modulators; Female; Fulvestrant; Humans; Mice; Mice, Nude; Neuropeptide Y; Receptors, Estrogen; Receptors, Neuropeptide Y; Tamoxifen | 2012 |
Pharmacologic downregulation of protein arginine methyltransferase1 expression by adenosine dialdehyde increases cell senescence in breast cancer.
Topics: Adenosine; Antineoplastic Combined Chemotherapy Protocols; Arginine; Betaine-Homocysteine S-Methyltransferase; Breast Neoplasms; Cell Cycle Checkpoints; Cell Proliferation; Cellular Senescence; Down-Regulation; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; Methylation; Molecular Docking Simulation; Oxidative Stress; Phosphatidylethanolamine N-Methyltransferase; Protein Processing, Post-Translational; Protein-Arginine N-Methyltransferases; Repressor Proteins; Signal Transduction; Tamoxifen | 2021 |
Downregulation of eNOS and preserved endothelial function in endothelial-specific arginase 1-deficient mice.
Topics: Animals; Arginase; Arginine; Down-Regulation; Endothelial Cells; Mice; Nitric Oxide; Nitric Oxide Synthase Type III; Ornithine; Tamoxifen; Urea | 2022 |
Clinical trials in cancer medicine.
Topics: Adult; Antineoplastic Agents; Bleomycin; Breast Neoplasms; Clinical Trials as Topic; Doxorubicin; Etoposide; Female; Humans; Male; Methotrexate; Platinum; Tamoxifen; Teniposide; Testicular Neoplasms | 1980 |